Relative Bioavailability of BI 10773 Given Alone and Together With Verapamil - an Open-label, Randomised, Crossover Trial in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2014
At a glance
- Drugs Empagliflozin (Primary) ; Verapamil
- Indications Angina pectoris; Arrhythmias; Hypertension; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 11 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2011 New trial record